Ptc Therapeutics
NASDAQ: PTCTSouth Plainfield, US · Delaware corporation · 2 known investors
Founders & leadership
SW
Stuart W. PeltzCo-founder
AS
Allan S. JacobsonCo-founder
ME
Mark E. BouldingExecutive
CU
Christine UtterExecutive
MS
Marcio SouzaExecutive
NA
Neil AlmsteadExecutive
MS
Michael SchmertzlerNamed on SEC filing
Board
DS
Dawn SvoronosBoard director
DP
David P. SouthwellBoard director
GD
Glenn D. Steele, Jr.Board director
JB
Jerome B. ZeldisBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$368.8M disclosed across 4 rounds · 2018–2023
▶$35.9MraisedMay 2023 · 40 investors · BiotechnologyRule 506(b)
▶$35.9MraisedMay 2023 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stepanie S. OkeyDirector
- Michael SchmertzlerDirector
- Matthew B. Klein, M.D.Executive Officer, Director
- Eric PauwelsExecutive Officer
- Alethia YoungDirector
- Neil Almstead, Ph.DExecutive Officer
- Glenn D. Steele Jr., M.D., Ph.D.Director
- David P. SouthwellDirector
- Emily HillExecutive Officer
- Jerome B. Zeldis, M.D., Ph.D.Director
- Mark E. BouldingExecutive Officer
- Christine UtterExecutive Officer
- Allan Jacobson, Ph.D.Director
- Emma ReeveDirector
- Mary SmithDirector
- Offering amount
- $35.9M
- Amount sold
- $35.9M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.9MraisedJun 2020 · 38 investors · BiotechnologyRule 506(b)
▶$41.9MraisedJun 2020 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark E. BouldingExecutive Officer
- Stuart W. PeltzExecutive Officer, Director
- Matthew KleinExecutive Officer
- David P. SouthwellDirector
- Michael SchmertzlerDirector
- Christine UtterExecutive Officer
- Emily HillExecutive Officer
- Eric PauwelsExecutive Officer
- Stephanie S. OkeyDirector
- Glenn D. Steele, Jr.Director
- Dawn SvoronosDirector
- Jerome B. ZeldisDirector
- Allan S. JacobsonDirector
- Emma ReeveDirector
- Neil AlmsteadExecutive Officer
- Offering amount
- $41.9M
- Amount sold
- $41.9M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$140.9MraisedMay 2020 · 57 investors · BiotechnologyRule 506(b)
▶$140.9MraisedMay 2020 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Emma ReeveDirector
- Jerome B. ZeldisDirector
- Christine UtterExecutive Officer
- Dawn SvoronosDirector
- Glenn D. Steele, Jr.Director
- Stephanie S. OkeyDirector
- Mark E. BouldingExecutive Officer
- Emily HillExecutive Officer
- Eric PauwelsExecutive Officer
- David P. SouthwellDirector
- Michael SchmertzlerDirector
- Stuart W. PeltzExecutive Officer, Director
- Allan S. JacobsonDirector
- Matthew B. KleinExecutive Officer
- Neil AlmsteadExecutive Officer
- Offering amount
- $140.9M
- Amount sold
- $140.9M
- Sales commissions
- $1.7M
- Placement agents
- SVB Leerink LLC
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150MraisedSep 2018 · 52 investors · BiotechnologyRule 506(b)
▶$150MraisedSep 2018 · 52 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dawn SvoronosDirector
- Stuart W. PeltzExecutive Officer, Director
- David P. SouthwellDirector
- Allan S. JacobsonDirector
- Mark E. BouldingExecutive Officer
- Christine UtterExecutive Officer
- Michael SchmertzlerDirector
- Glenn D. Steele, Jr.Director
- Marcio SouzaExecutive Officer
- Jerome B. ZeldisDirector
- Neil AlmsteadExecutive Officer
- Offering amount
- $150M
- Amount sold
- $150M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Ptc Therapeutics?
- Ptc Therapeutics was founded by Stuart W. Peltz, Allan S. Jacobson.
- Who are Ptc Therapeutics's investors?
- Ptc Therapeutics's investors include Bay City Capital, Longwood Fund.
- How much funding has Ptc Therapeutics raised?
- Ptc Therapeutics has disclosed $368.8M raised across 4 rounds.
- Where is Ptc Therapeutics headquartered?
- Ptc Therapeutics is headquartered in South Plainfield, US.